Immunoglobulins of Patients Recovering fromYersinia enterocoliticaInfections Exhibit Graves' Disease-like Activity in Human Thyroid Membranes
- 1 January 1991
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 1 (4) , 315-320
- https://doi.org/10.1089/thy.1991.1.315
Abstract
Substantial evidence suggests a link between infections with Yersinia enterocolitica (YE) and Graves' disease. We have now examined the sera of 72 patients recovering from YE infection for immunoglobulins that interacted with the TSH receptor in human thyroid membranes. Compared with controls, in concentrations between 1 and 4 mg/mL, patient IgG produced a significant, concentration-dependent inhibition of TSH binding (p < 0.001) and stimulation of adenylate cyclase activity (p < 0.005–0.05). Whereas IgG from normal individuals caused no stimulation of adenylate cyclase, IgG from controls caused some concentration-dependent displacement of TSH, as previously reported. However, IgG from convalescents of YE infections was significantly more potent than normal IgG in reducing the binding of TSH to the membranes. Thus, at each examined concentration, YE patients' IgG displaced more TSH than IgG from normal controls. For each milligram per milliter increment of IgG in the assay, patients' IgG caused a 10.2% inhibition of TSH binding (r -0.90, p < 0.001), significantly greater than that seen with normal IgG (p < 0.02). The present studies provide the first demonstration that IgG of patients recovering from YE infections react with the human TSH receptor. The antibodies presumably are produced against the TSH-binding protein present in YE. However, in view of lack of evidence for thyroid dysfunction in the sera of patients recovering from yersiniosis and the presence of TSH-binding proteins in other bacteria, we postulate that infection with YE is neither necessary nor sufficient to cause thyroid autoimmune disease. Instead, we propose that YE, as well as infections by other bacteria containing TSH receptorlike proteins, may aim an autoimmune process to the thyroid gland in individuals otherwise predisposed to autoimmune disease.Keywords
This publication has 20 references indexed in Scilit:
- Patients with autoimmune thyroid diseases have antibodies to plasmid encoded proteins of enteropathogenic YersiniaJournal of Endocrinological Investigation, 1988
- ANTIBODIES TO PLASMID-ENCODED PROTEINS OF ENTEROPATHOGENIC YERSINIA IN PATIENTS WITH AUTOIMMUNE THYROID DISEASEThe Lancet, 1988
- Receptors for intercellular messenger molecules in microbes: Similarities to vertebrate receptors and possible implications for diseases in manCellular and Molecular Life Sciences, 1986
- Sharing of Antigenic Determinants between the Nicotinic Acetylcholine Receptor and Proteins inEscherichia coli, Proteus vulgaris,andKlebsiella pneumoniaeNew England Journal of Medicine, 1985
- Heterogeneity of the Graves' Immunoglobulins Directed toward the Thyrotropin Receptor-Adenylate Cyclase System*Journal of Clinical Endocrinology & Metabolism, 1983
- Two major genes, linked to HLA and Gm, control susceptibility to Graves' diseaseNature, 1981
- HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical courseActa Endocrinologica, 1981
- Cell‐Mediated Immunity to Yersinia enterocolitica Serotype 3 in Patients with Thyroid DiseasesAllergy, 1978
- YERSINIA ENTEROCOLITICA INFECTION AND THYROID DISEASESActa Endocrinologica, 1977
- ANTIBODIES AGAINST THYROID CELLS IN YERSINIA ENTEROCOLITICA INFECTIONThe Lancet, 1974